Skip to main content
Premium Trial:

Request an Annual Quote

Repositive Raises $721K From Investors

NEW YORK (GenomeWeb) – Software company Repositive has received £500,000 (about $721,000) in seed funding from Amadeus Capital, Seedcamp, ClearlySo, Cambridge Angels, and Jonathan Milner.

The company said it will use the funds to further develop a platform that helps researchers access and use genomic datasets, and provides a forum for initiating collaborations with colleagues in the community. The product is currently in beta testing, and Repositive plans to use the seed financing to fully develop and launch it.

The new funds will also help the company scale up both the user capacity and professional services on its platform, before starting a Series A fundraising in 2016. Planned features include premium services both for enterprise and non-enterprise users, including improved tools for assessing data quality and availability from both public and private data providers, Repositive said. In addition to its investment, Seedcamp is also providing tailored business support that will help the company grow.

"We have a strong and growing user base and with this funding we will be able to deliver an improved platform and additional services for all of our users," Repositive's CEO Fiona Nielsen said in a statement. It will also "bring us to public launch of the Repositive platform to build upon our popularity and success with beta users."